Repositioning Candidates
Repositioning candidates for CKD are derived from DrugBank which fall into three categories: therapeutic strategy-associated, target-associated, and indication-associated candidates. For each candidate, detailed properties are extracted from DrugBank, and related strategies, target and CKD-associated disease in CKDdb are presented with knowledge graphs.
stats1
stats2
stats3
Search for:
PPAR11 records.
Candidate ID | Source ID | Source Type | Compound Type | Candidate Name | Inclusion Criteria | |
---|---|---|---|---|---|---|
R0003 | DB00050 | approved; investigational | small molecule | Cetrorelix | Details | |
R0024 | DB00146 | approved; nutraceutical | small molecule | Calcifediol | Details | |
R0067 | DB00257 | approved; vet_approved | small molecule | Clotrimazole | Details | |
R0111 | DB00399 | approved | small molecule | Zoledronic acid | Details | |
R0112 | DB00402 | approved; investigational | small molecule | Eszopiclone | Details | |
R0135 | DB00480 | approved | small molecule | Lenalidomide | Details | |
R0153 | DB00542 | approved; investigational | small molecule | Benazepril | Details | |
R0160 | DB00571 | approved; investigational | small molecule | Propranolol | Details | |
R0170 | DB00601 | approved; investigational | small molecule | Linezolid | Details | |
R0188 | DB00668 | approved; vet_approved | small molecule | Epinephrine | Details | |
R0199 | DB00695 | approved; vet_approved | small molecule | Furosemide | Details |